A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment

Cancer

Volumn 123, Issue 6, 2017, Pages 928-939

  Shih, Ya Chen Tina ^a   Chien, Chun Ru ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cost transparency; outcomes; patient attitudes; patient physician cost communication; physician acceptance

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER PATIENT; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; FINANCIAL DEFICIT; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL CARE; MEDICAL FEE; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL SOCIETY; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW; ATTITUDE; ECONOMICS; META ANALYSIS; NEOPLASMS; PATIENT; PHYSICIAN; PROFESSIONAL-PATIENT RELATIONSHIP;

ATTITUDE; COMMUNICATION; HEALTH CARE COSTS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENTS; PHYSICIANS; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF HEALTH CARE;

EID: 85006102555     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30423     Document Type: Review

References (28)

1. Hillner BE, Smith TJ. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol. 2007;25:611–613.
2. Schrag D. The price tag on progress—chemotherapy for colorectal cancer. N Engl J Med. 2004;351:317–319.
3. Scalo JF, Rascati KL. Trends and issues in oncology costs. Expert Rev Pharmacoecon Outcomes Res. 2014;14:35–44.
4. Shih YC, Ganz PA, Aberle D, et al. Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol. 2013;31:4151–4157.
5. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27:3868–3874.
6. Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: Institute of Medicine; 2013.
7. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290:953–958.
8. Schrag D, Hanger M. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol. 2007;25:233–237.
9. Neumann PJ, Palmer JA, Nadler E, Fang C, Ubel P. Cancer therapy costs influence treatment: a national survey of oncologists. Health Aff (Millwood). 2010;29:196–202.
10. Irwin B, Kimmick G, Altomare I, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19:1135–1140.
11. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269, W264.
12. Berry SR, Bell CM, Ubel PA, et al. Continental divide?. The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. J Clin Oncol. 2010;28:4149–4153.
13. Bestvina CM, Zullig LL, Rushing C, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10:162–167.
14. Zafar SY, Chino F, Ubel PA, et al. The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care. 2015;21:607–615.
15. Hunter WG, Hesson A, Davis JK, et al. Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates [serial online]. BMC Health Serv Res. 2016;16:108.
16. Hunter WG, Zhang CZ, Hesson A, et al. What strategies do physicians and patients discuss to reduce out-of-pocket costs?. Analysis of cost-saving strategies in 1755 outpatient clinic visits. Med Decis Making. 2016;36:900–910.
17. Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ. Patients and physicians can discuss costs of cancer treatment in the clinic. J Oncol Pract. 2015;11:308–312.
18. Kaser E, Shaw J, Marven M, Swinburne L, Boyle F. Communication about high-cost drugs in oncology—the patient view. Ann Oncol. 2010;21:1910–1914.
19. Meisenberg BR, Varner A, Ellis E, et al. Patient attitudes regarding the cost of illness in cancer care. Oncologist. 2015;20:1199–1204.
20. Bullock AJ, Hofstatter EW, Yushak ML, Buss MK. Understanding patients' attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012;8:e50–e58.
21. Henrikson NB, Tuzzio L, Loggers ET, Miyoshi J, Buist DS. Patient and oncologist discussions about cancer care costs. Support Care Cancer. 2014;22:961–967.
22. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18:381–390.
23. Jung OS, Guzzo T, Lee D, et al. Out-of-pocket expenses and treatment choice for men with prostate cancer. Urology. 2012;80:1252–1257.
24. DeNavas-Walt C, Proctor BD. Income and Poverty in the United States: 2014. US Census Bureau, Current Population Report P60-252. Washington, DC; United States Census Bureau; 2015.
25. Altomare I, Irwin B, Zafar SY, et al. Physician experience and attitudes toward addressing the cost of cancer care. J Oncol Pract. 2016;12:e281–e288, e247-e288.
26. Schickedanz A. Of value: a discussion of cost, communication, and evidence to improve cancer care. Oncologist. 2010;15(suppl 1):73–79.
27. Peppercorn J. The financial burden of cancer care: do patients in the US know what to expect? Expert Rev Pharmacoecon Outcomes Res. 2014;14:835–842.
28. Hofstatter EW. Understanding patient perspectives on communication about the cost of cancer care: a review of the literature. J Oncol Pract. 2010;6:188–192.